Clinicopathological profile and prognosis of idiopathic membranous nephropathy in adults: a developing country perspective

Background: There is no study available from Pakistan on the longitudinal course of membranous nephropathy (MN). We aimed to analyse the clinicopathological profile, course, response to treatment and outcome of the disease in our setup. Methods: All consecutive adult patients (≥18 years) with MN on renal biopsy and on regular follow-up were included. Relevant data items were retrieved from case files and biopsy reports. The outcome variables included doubling of baseline serum creatinine or the development of end-stage renal disease (ESRD). Results: Of a total of 102 patients, 82 (80.4%) were males; mean age was 28.9±11.4 years. Peripheral oedema was present in 86 (84.3%), nephrotic-range proteinuria in 80 (78.4%), microscopic haematuria in 25 (24.5%), hypertension in 42 (41.2%), and renal dysfunction in 13 (12.7%) patients at the time of presentation. The mean follow-up period was 3±2 years. Overall, 22 (21.5%) subjects went into remission and a similar number experienced doubling of serum creatinine. Both conservative and immunosuppressive treatment groups had similar duration of follow-up. The proportion of patients with remission and doubling of serum creatinine was similar between the two groups (p=0.70 and p=0.91 respectively), while the proportion of patients progressing to ESRD was significantly higher in the group treated conservatively (p=0.03). Baseline proteinuria and serum creatinine were predictive of remission (p=0.04 and p=0.05 respectively). Conclusions: In conclusion, untreated MN has a higher risk of progression to ESRD. Baseline proteinuria and serum creatinine predict response to treatment. Randomised controlled trials are needed to confirm the effects of immunosuppressive treatment

Saved in:
Bibliographic Details
Main Authors: Hyder Rizvi,Syed Abbas, Naqvi,Rubina, Ahmed,Ejaz, Akhter,Fazal, Abbas,Khawar, Mubarak,Muhammed
Format: Digital revista
Language:English
Published: Sociedade Portuguesa de Nefrologia 2016
Online Access:http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692016000200006
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S0872-01692016000200006
record_format ojs
spelling oai:scielo:S0872-016920160002000062016-07-29Clinicopathological profile and prognosis of idiopathic membranous nephropathy in adults: a developing country perspectiveHyder Rizvi,Syed AbbasNaqvi,RubinaAhmed,EjazAkhter,FazalAbbas,KhawarMubarak,Muhammed Adults end-stage renal disease membranous nephropathy nephrotic syndrome proteinuria Background: There is no study available from Pakistan on the longitudinal course of membranous nephropathy (MN). We aimed to analyse the clinicopathological profile, course, response to treatment and outcome of the disease in our setup. Methods: All consecutive adult patients (≥18 years) with MN on renal biopsy and on regular follow-up were included. Relevant data items were retrieved from case files and biopsy reports. The outcome variables included doubling of baseline serum creatinine or the development of end-stage renal disease (ESRD). Results: Of a total of 102 patients, 82 (80.4%) were males; mean age was 28.9±11.4 years. Peripheral oedema was present in 86 (84.3%), nephrotic-range proteinuria in 80 (78.4%), microscopic haematuria in 25 (24.5%), hypertension in 42 (41.2%), and renal dysfunction in 13 (12.7%) patients at the time of presentation. The mean follow-up period was 3±2 years. Overall, 22 (21.5%) subjects went into remission and a similar number experienced doubling of serum creatinine. Both conservative and immunosuppressive treatment groups had similar duration of follow-up. The proportion of patients with remission and doubling of serum creatinine was similar between the two groups (p=0.70 and p=0.91 respectively), while the proportion of patients progressing to ESRD was significantly higher in the group treated conservatively (p=0.03). Baseline proteinuria and serum creatinine were predictive of remission (p=0.04 and p=0.05 respectively). Conclusions: In conclusion, untreated MN has a higher risk of progression to ESRD. Baseline proteinuria and serum creatinine predict response to treatment. Randomised controlled trials are needed to confirm the effects of immunosuppressive treatmentinfo:eu-repo/semantics/openAccessSociedade Portuguesa de NefrologiaPortuguese Journal of Nephrology & Hypertension v.30 n.2 20162016-06-01info:eu-repo/semantics/articletext/htmlhttp://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692016000200006en
institution SCIELO
collection OJS
country Portugal
countrycode PT
component Revista
access En linea
databasecode rev-scielo-pt
tag revista
region Europa del Sur
libraryname SciELO
language English
format Digital
author Hyder Rizvi,Syed Abbas
Naqvi,Rubina
Ahmed,Ejaz
Akhter,Fazal
Abbas,Khawar
Mubarak,Muhammed
spellingShingle Hyder Rizvi,Syed Abbas
Naqvi,Rubina
Ahmed,Ejaz
Akhter,Fazal
Abbas,Khawar
Mubarak,Muhammed
Clinicopathological profile and prognosis of idiopathic membranous nephropathy in adults: a developing country perspective
author_facet Hyder Rizvi,Syed Abbas
Naqvi,Rubina
Ahmed,Ejaz
Akhter,Fazal
Abbas,Khawar
Mubarak,Muhammed
author_sort Hyder Rizvi,Syed Abbas
title Clinicopathological profile and prognosis of idiopathic membranous nephropathy in adults: a developing country perspective
title_short Clinicopathological profile and prognosis of idiopathic membranous nephropathy in adults: a developing country perspective
title_full Clinicopathological profile and prognosis of idiopathic membranous nephropathy in adults: a developing country perspective
title_fullStr Clinicopathological profile and prognosis of idiopathic membranous nephropathy in adults: a developing country perspective
title_full_unstemmed Clinicopathological profile and prognosis of idiopathic membranous nephropathy in adults: a developing country perspective
title_sort clinicopathological profile and prognosis of idiopathic membranous nephropathy in adults: a developing country perspective
description Background: There is no study available from Pakistan on the longitudinal course of membranous nephropathy (MN). We aimed to analyse the clinicopathological profile, course, response to treatment and outcome of the disease in our setup. Methods: All consecutive adult patients (≥18 years) with MN on renal biopsy and on regular follow-up were included. Relevant data items were retrieved from case files and biopsy reports. The outcome variables included doubling of baseline serum creatinine or the development of end-stage renal disease (ESRD). Results: Of a total of 102 patients, 82 (80.4%) were males; mean age was 28.9±11.4 years. Peripheral oedema was present in 86 (84.3%), nephrotic-range proteinuria in 80 (78.4%), microscopic haematuria in 25 (24.5%), hypertension in 42 (41.2%), and renal dysfunction in 13 (12.7%) patients at the time of presentation. The mean follow-up period was 3±2 years. Overall, 22 (21.5%) subjects went into remission and a similar number experienced doubling of serum creatinine. Both conservative and immunosuppressive treatment groups had similar duration of follow-up. The proportion of patients with remission and doubling of serum creatinine was similar between the two groups (p=0.70 and p=0.91 respectively), while the proportion of patients progressing to ESRD was significantly higher in the group treated conservatively (p=0.03). Baseline proteinuria and serum creatinine were predictive of remission (p=0.04 and p=0.05 respectively). Conclusions: In conclusion, untreated MN has a higher risk of progression to ESRD. Baseline proteinuria and serum creatinine predict response to treatment. Randomised controlled trials are needed to confirm the effects of immunosuppressive treatment
publisher Sociedade Portuguesa de Nefrologia
publishDate 2016
url http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-01692016000200006
work_keys_str_mv AT hyderrizvisyedabbas clinicopathologicalprofileandprognosisofidiopathicmembranousnephropathyinadultsadevelopingcountryperspective
AT naqvirubina clinicopathologicalprofileandprognosisofidiopathicmembranousnephropathyinadultsadevelopingcountryperspective
AT ahmedejaz clinicopathologicalprofileandprognosisofidiopathicmembranousnephropathyinadultsadevelopingcountryperspective
AT akhterfazal clinicopathologicalprofileandprognosisofidiopathicmembranousnephropathyinadultsadevelopingcountryperspective
AT abbaskhawar clinicopathologicalprofileandprognosisofidiopathicmembranousnephropathyinadultsadevelopingcountryperspective
AT mubarakmuhammed clinicopathologicalprofileandprognosisofidiopathicmembranousnephropathyinadultsadevelopingcountryperspective
_version_ 1756001680538730496